Table 4.
Factor | Median OS (date) | P value |
---|---|---|
Age (years): <65 versus ≧65 | 943 versus 979 | 0.528 |
Male versus female | 711 versus 1,166 | 0.111 |
Location: body‐tail versus head | 1,166 versus 943 | 0.52 |
Tumor size (mm): <30 versus ≧30 | 1,010 versus 711 | <0.05 |
T1–2 versus T3–4 | 979 versus 847 | 0.216 |
N: N0 versus N1 | 1,184 versus 646 | <0.05 |
CA19‐9 (U/ml): <200 versus ≧200 | 1,097 versus 602 | <0.01 |
Adjuvant chemotherapy: (−) versus (+) | 537 versus 1,163 | <0.01 |
HbA1c (%): <6.5 versus ≧6.5 | 1,166 versus 742 | <0.05 |
DM: (−) versus (+) | 1,184 versus 847 | 0.074 |
Long‐DM: (−) versus (+) | 1,066 versus 632 | <0.05 |
miR‐100‐5p expression: <4.13 versus ≧4.13 | 1,184 versus 703 | <0.05 |
CDH1 promoter methylation: (−) versus (+) | 1,001 versus 602 | <0.01 |